Exact Mass: 319.0975148

Exact Mass Matches: 319.0975148

Found 120 metabolites which its exact mass value is equals to given mass value 319.0975148, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tetrodotoxin

(1R,5R,6R,7R,9S,11R,12R,13S,14S)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1(7,11).0(1,6)]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1015602)

A quinazoline alkaloid that is a marine toxin isolated from fish such as puffer fish. It has been shown to exhibit potential neutotoxicity due to its ability to block voltage-gated sodium channels. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Tetrodotoxin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=4368-28-9 (retrieved 2024-09-06) (CAS RN: 4368-28-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

RO19-4603

Ro 19-4603

C15H17N3O3S (319.09905720000006)

Benzamil

3,5-diamino-N-(N-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide

C13H14ClN7O (319.0948304)

ci no 52015

Methylthioninium Chloride

C16H18ClN3S (319.09098980000005)

V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CG - Tests for gastric secretion COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Ibandronate

{1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonic acid

C9H23NO7P2 (319.0949708)

Ibandronate is a nitrogen-containing bisphosphonate in the same class as alendronate and risedronate. Ibandronate inhibits osteoclast-mediated bone resorption. All of the bisphosphonates prevent the breakdown of bone by bone cells called osteoclasts. In persons who are at high risk for osteoporosis, bisphosphonates not only result in increased amounts of bone and bone strength, they also reduce the risk of hip fractures and other bone fractures. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

N-(p-Toluenesulfonyl)-L-phenylalanine

2-(4-methylbenzenesulfonamido)-3-phenylpropanoic acid

C16H17NO4S (319.08782420000006)

5,9:7,10a-Dimethano-10aH-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-,(4R,4aR,5R,7S,9S,10S,10aR,11S,12S)-

C11H17N3O8 (319.1015602)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D049990 - Membrane Transport Modulators

1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea

1-(2-Methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea hydrochloride

C17H13N5O2 (319.1069198)

(1R,3S)-1-(5-hydroxymethylfuran-2-yl)-3-carboxy-6-hydroxy-8-methoxy-1,2,3,4-tetrahydroisoquinoline

(1R*,3S*)-1-(5-hydroxymethylfuran-2-yl)-3-carboxy-6-hydroxy-8-methoxy-1,2,3,4-tetrahydroisoquinoline

C16H17NO6 (319.1055822)

2-(3,4-dihydro-2-methoxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine B

C18H13N3O3 (319.09568680000007)

Ala Asp Asp

C11H17N3O8 (319.1015602)

Gly Asp Glu

C11H17N3O8 (319.1015602)

Gly Glu Asp

C11H17N3O8 (319.1015602)

Asp Ala Asp

C11H17N3O8 (319.1015602)

Asp Asp Ala

C11H17N3O8 (319.1015602)

MMV202458

C17H18NO3Cl (319.09751480000006)

1,N2-6-Oxo-malondialdehyde-deoxyguanosine

C13H13N5O5 (319.09166480000005)

Asp Gly Glu

C11H17N3O8 (319.1015602)

Glu Gly Asp

C11H17N3O8 (319.1015602)

Glu Asp Gly

C11H17N3O8 (319.1015602)

Asp Glu Gly

C11H17N3O8 (319.1015602)

Ibandronate

Ibandronate sodium;Ibandronate sodium monohydrate;Ibandronic Acid;R484

C9H23NO7P2 (319.0949708)

M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

N-BOC-2-(3-TRIFLUOROMETHYLPHENYL)-DL-GLYCINE

C14H16F3NO4 (319.1031372)

N-Boc-2-(4-trifluoromethylphenyl)-DL-glycine

C14H16F3NO4 (319.1031372)

(S)-(+)-Norepinephrine L-bitartrate

C12H17NO9 (319.09032720000005)

METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-5-(TRIFLUOROMETHYL)BENZOATE

C14H16F3NO4 (319.1031372)

boc-l-2,4,5-trifluorophe

C14H16F3NO4 (319.1031372)

(r)-phenyl-(toluene-4-sulfonylamino)-acetic acid methyl ester

C16H17NO4S (319.08782420000006)

methyl 3-[(2,4-dimethylphenyl)sulfonylamino]benzoate

C16H17NO4S (319.08782420000006)

METHYL 2-(4-METHYLPHENYLSULFONAMIDO)-2-PHENYLACETATE

C16H17NO4S (319.08782420000006)

(R)-2-(4-Methylphenylsulfonamido)-3-phenylpropanoicacid

C16H17NO4S (319.08782420000006)

METHYL 4-(ETHYLCARBAMOYL)-2,3-DIFLUORO-[1,1-BIPHENYL]-3-CARBOXYLATE

C17H15F2NO3 (319.1019944000001)

Norepinephrine Bitartrate

C12H17NO9 (319.09032720000005)

1-Azulenesulfonic acid, 3,8-dimethyl-5-(1-methylethyl)-, sodium salt, hydrate (2:2:1)

C15H20NaO4S (319.097994)

2-[2-(4-morpholin-4-ylanilino)-1,3-thiazol-4-yl]acetic acid

C15H17N3O3S (319.09905720000006)

N-(2,3-Dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-2-naphthalenecarboxamide

C18H13N3O3 (319.09568680000007)

4-(6-METHOXY-2-NAPHTHYL)-6-(TRIFLUOROMETHYL)PYRIMIDIN-2-AMINE

C16H12F3N3O (319.0932418)

Ro 19-4603

Tert-butyl 5-methyl-6-oxo-5,6-dihydro-4h-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylate

C15H17N3O3S (319.09905720000006)

boc-d-3,4,5-trifluorophenylalanine

C14H16F3NO4 (319.1031372)

N-[5-Acetyl-2-(benzyloxy)phenyl]methanesulfonamide

C16H17NO4S (319.08782420000006)

(R)-ethyl 2-(1-(benzyloxycarbonyl)ethyl)thiazole-5-carboxylate

C16H17NO4S (319.08782420000006)

Fenamiphos metabolite

C13H22NO4PS (319.10071020000004)

METHYL 2-((ISOPROPOXYCARBONYL)AMINO)-5-METHYL-4-(TRIFLUOROMETHYL)BENZOATE

C14H16F3NO4 (319.1031372)

[(1R)-1-(benzyloxycarbonylamino)-2-phenyl-ethyl]phosphinic acid

C16H18NO4P (319.09733980000004)

Noradrenaline tartrate

C12H17NO9 (319.09032720000005)

N-p-Tosyl-L-phenylalanine

C16H17NO4S (319.08782420000006)

METHYL N-P-TOLUENESULFONYL-L-2-PHENYLGLYCINATE

C16H17NO4S (319.08782420000006)

Ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate

C16H17NO6 (319.1055822)

boc-d-2,4,5-trifluorophe

C14H16F3NO4 (319.1031372)

Febuxostat impurity 8

C16H17NO4S (319.08782420000006)

9,10 - dimethylacridinium methyl sulfate

C16H17NO4S (319.08782420000006)

3-[3-Acetyl-4-hydroxy-2-(4-methoxy-phenyl)-5-oxo-2,5-dihydro-pyrrol-1-yl]-propionic acid

C16H17NO6 (319.1055822)

Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate

C16H17NO6 (319.1055822)

(3-Fluoro-4-(((4-methoxybenzyl)oxy)carbamoyl)phenyl)boronic acid

C15H15BFNO5 (319.1027262)

(Trimethyl)methylcyclopentadienylplatinum(IV)

C9H16Pt (319.0899786)

Norepinephrine tartrate

C12H17NO9 (319.09032720000005)

2-[benzyl-(4-methylphenyl)sulfonyl-amino]acetic acid

C16H17NO4S (319.08782420000006)

boc-l-3,4,5-trifluorophenylalanine

C14H16F3NO4 (319.1031372)

Nitrazolam

C17H13N5O2 (319.1069198)

2-([(4-Methylphenyl)sulfonyl]amino)-3-phenylpropanoic acid

C16H17NO4S (319.08782420000006)

Glutamyl-aspartyl-glycine

C11H17N3O8 (319.1015602)

(11R,13S)-3-amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo[7.3.1.17,11.01,6]tetradec-3-en-9-olate

C11H17N3O8 (319.1015602)

ibandronic acid

C9H23NO7P2 (319.0949708)

(11S,13S)-3-Amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo[7.3.1.17,11.01,6]tetradec-3-en-9-olate

C11H17N3O8 (319.1015602)

1-(4-Ethyl-2-pyridinyl)-3-(4-methylphenyl)sulfonylurea

C15H17N3O3S (319.09905720000006)

Asp-Gly-Glu

C11H17N3O8 (319.1015602)

Asp-Ala-Asp

C11H17N3O8 (319.1015602)

Asp-Glu-Gly

C11H17N3O8 (319.1015602)

4-acetyl-3,5-dimethyl-1H-pyrrole-2-carboxylic acid (5-methoxycarbonyl-2-furanyl)methyl ester

C16H17NO6 (319.1055822)

N-(1,3-benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidinamine

C18H13N3O3 (319.09568680000007)

2-(4-Chlorophenyl)-4-(ethylthio)-6-(1-pyrrolidinyl)pyrimidine

C16H18ClN3S (319.09098980000005)

Ala-Asp-Asp

C11H17N3O8 (319.1015602)

Gly-Asp-Glu

C11H17N3O8 (319.1015602)

Gly-Glu-Asp

C11H17N3O8 (319.1015602)

Glu-Gly-Asp

C11H17N3O8 (319.1015602)

Asp-Asp-Ala

C11H17N3O8 (319.1015602)

Aspartyl-glycyl-glutamic acid

C11H17N3O8 (319.1015602)

(11S,13S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.17,11.01,6]tetradec-3-ene-5,9,12,13,14-pentol

C11H17N3O8 (319.1015602)

(2S)-N-(4-chloro-2-methylphenyl)-2-(4-methoxyphenoxy)propanamide

C17H18ClNO3 (319.0975148)

Benzamil

C13H14ClN7O (319.0948304)

SB 334867

1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea

C17H13N5O2 (319.1069198)

Glu-Asp-Gly

C11H17N3O8 (319.1015602)

Ro 67-7476

C17H18FNO2S (319.10422200000005)

Ro 67-7476 is a potent positive allosteric modulator of mGluR1 and potentiates glutamate-induced calcium release in HEK293 cells expressing rat mGluR1a with an EC50 of 60.1 nM[1][2]. Ro 67-7476 is a potent P-ERK1/2 agonist?and activates ERK1/2 phosphorylation in the absence of exogenously added glutamate (EC50=163.3 nM)[3].